These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Spectrum and prevalence of FP/TMEM127 gene mutations in pheochromocytomas and paragangliomas. Yao L; Schiavi F; Cascon A; Qin Y; Inglada-Pérez L; King EE; Toledo RA; Ercolino T; Rapizzi E; Ricketts CJ; Mori L; Giacchè M; Mendola A; Taschin E; Boaretto F; Loli P; Iacobone M; Rossi GP; Biondi B; Lima-Junior JV; Kater CE; Bex M; Vikkula M; Grossman AB; Gruber SB; Barontini M; Persu A; Castellano M; Toledo SP; Maher ER; Mannelli M; Opocher G; Robledo M; Dahia PL JAMA; 2010 Dec; 304(23):2611-9. PubMed ID: 21156949 [TBL] [Abstract][Full Text] [Related]
10. Whole Exome Sequencing Identifies Novel Genetic Alterations in Patients with Pheochromocytoma/Paraganglioma. Seo SH; Kim JH; Kim MJ; Cho SI; Kim SJ; Kang H; Shin CS; Park SS; Lee KE; Seong MW Endocrinol Metab (Seoul); 2020 Dec; 35(4):909-917. PubMed ID: 33397043 [TBL] [Abstract][Full Text] [Related]
11. Whole exome sequencing is an efficient and sensitive method for detection of germline mutations in patients with phaeochromcytomas and paragangliomas. McInerney-Leo AM; Marshall MS; Gardiner B; Benn DE; McFarlane J; Robinson BG; Brown MA; Leo PJ; Clifton-Bligh RJ; Duncan EL Clin Endocrinol (Oxf); 2014 Jan; 80(1):25-33. PubMed ID: 24102379 [TBL] [Abstract][Full Text] [Related]
12. Increased HIF1 alpha in SDH and FH deficient tumors does not cause microsatellite instability. Lehtonen HJ; Mäkinen MJ; Kiuru M; Laiho P; Herva R; van Minderhout I; Hogendoorn PC; Cornelisse C; Devilee P; Launonen V; Aaltonen LA Int J Cancer; 2007 Sep; 121(6):1386-9. PubMed ID: 17520677 [TBL] [Abstract][Full Text] [Related]
13. 15 YEARS OF PARAGANGLIOMA: Genetics and mechanism of pheochromocytoma-paraganglioma syndromes characterized by germline SDHB and SDHD mutations. Baysal BE; Maher ER Endocr Relat Cancer; 2015 Aug; 22(4):T71-82. PubMed ID: 26113606 [TBL] [Abstract][Full Text] [Related]
14. The connection between tricarboxylic acid cycle enzyme mutations and pseudohypoxic signaling in pheochromocytoma and paraganglioma. Wang Y; Liu B; Li F; Zhang Y; Gao X; Wang Y; Zhou H Front Endocrinol (Lausanne); 2023; 14():1274239. PubMed ID: 37867526 [TBL] [Abstract][Full Text] [Related]
15. Gain-of-function mutations in DNMT3A in patients with paraganglioma. Remacha L; Currás-Freixes M; Torres-Ruiz R; Schiavi F; Torres-Pérez R; Calsina B; Letón R; Comino-Méndez I; Roldán-Romero JM; Montero-Conde C; Santos M; Pérez LI; Pita G; Alonso MR; Honrado E; Pedrinaci S; Crespo-Facorro B; Percesepe A; Falcioni M; Rodríguez-Perales S; Korpershoek E; Ramón-Maiques S; Opocher G; Rodríguez-Antona C; Robledo M; Cascón A Genet Med; 2018 Dec; 20(12):1644-1651. PubMed ID: 29740169 [TBL] [Abstract][Full Text] [Related]
18. SDHA immunohistochemistry detects germline SDHA gene mutations in apparently sporadic paragangliomas and pheochromocytomas. Korpershoek E; Favier J; Gaal J; Burnichon N; van Gessel B; Oudijk L; Badoual C; Gadessaud N; Venisse A; Bayley JP; van Dooren MF; de Herder WW; Tissier F; Plouin PF; van Nederveen FH; Dinjens WN; Gimenez-Roqueplo AP; de Krijger RR J Clin Endocrinol Metab; 2011 Sep; 96(9):E1472-6. PubMed ID: 21752896 [TBL] [Abstract][Full Text] [Related]
19. Germline mutations and genotype-phenotype correlations in patients with apparently sporadic pheochromocytoma/paraganglioma in Korea. Kim JH; Seong MW; Lee KE; Choi HJ; Ku EJ; Bae JH; Park SS; Choi SH; Kim SW; Shin C; Kim SY Clin Genet; 2014 Nov; 86(5):482-6. PubMed ID: 24134185 [TBL] [Abstract][Full Text] [Related]
20. Genetic analysis of mitochondrial complex II subunits SDHD, SDHB and SDHC in paraganglioma and phaeochromocytoma susceptibility. Astuti D; Hart-Holden N; Latif F; Lalloo F; Black GC; Lim C; Moran A; Grossman AB; Hodgson SV; Freemont A; Ramsden R; Eng C; Evans DG; Maher ER Clin Endocrinol (Oxf); 2003 Dec; 59(6):728-33. PubMed ID: 14974914 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]